EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • March 3rd, 2015 • Durect Corp • Pharmaceutical preparations • Virginia
THIS EXCLUSIVE LICENSE AGREEMENT is made and entered into this 5th day of December, 2012, by and between: DURECT CORPORATION, a Delaware corporation (hereinafter referred to as the “LICENSEE”) with its principal place of business at 10260 Bubb Road, Cupertino, CA 95014, and VIRGINIA COMMONWEALTH UNIVERSITY INTELLECTUAL PROPERTY FOUNDATION (hereinafter referred to as the “LICENSOR”), and with its principal place of operation at Virginia Commonwealth University, 800 E. Leigh Street, Suite 3000, Richmond, Virginia 23298-0568.
LICENSE AGREEMENT by and between Durect Corporation and Santen Pharmaceutical Co., Ltd. Dated December 11, 2014License Agreement • March 3rd, 2015 • Durect Corp • Pharmaceutical preparations
This LICENSE AGREEMENT (the “Agreement”) is effective as of December 11, 2014 (the “Effective Date”) by and between Durect Corporation, a Delaware company having offices located at 10260 Bubb Road, Cupertino, CA 95014, U.S.A. (“Durect”) and Santen Pharmaceutical Co., Ltd., a Japanese corporation having offices located at 4-20 Ofukacho, Kita-ku, Osaka 530-8552, Japan (“Santen”). Santen and Durect are each referred to herein by name or, individually, as a “Party” or, collectively, as “Parties.”
